Pluri Inc. is a biotechnology company focused on advancing cell therapy and regenerative medicine through its innovative technologies. The company specializes in developing and commercializing products and therapies aimed at treating incurable diseases and addressing unmet medical needs. By harnessing the power of pluripotent stem cells and advanced genetic engineering techniques, Pluri seeks to transform the landscape of medical treatment, offering new hope for patients suffering from a range of conditions. Their commitment to scientific research and development drives their goal to create effective, safe, and accessible cellular therapies for a better quality of life. Read More
NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.
HAIFA, ISRAEL / ACCESSWIRE / November 12, 2024 / Pluri Inc. (NASDAQ:PLUR), a leading biotechnology company that offers cell-based solutions for various industries. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Investor Summit Group, an independent organization focused on creating networking opportunities for the MicroCap and SmallCap community, has announced that presentations from the August 20 Microcap Investor Summit Virtual 2024 Conference are now accessible for on-demand viewing.
